In an email from the company, they said they're still progressing Goulamina because if the sale doesn't get approved we'll still be a shareholder of Goulamina. I mean that's technically true, but I don't see how it won't get approved. We'd be fkd otherwise, right?
Thoughts from anyone? Who's voting against the sale?
In an email from the company, they said they're still...
Add LLL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
50.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $498.5M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| LLL (ASX) Chart |
Day chart unavailable